Organigram Global Inc

Organigram Global Inc(OGI)股票分析

$0.930

-0.034 (-3.65%)收盘时

Loading chart…
最高
0.980
开盘
0.980
成交量加权均价
0.93
成交量
1.66M
市值
164.80M
最低
0.890
成交额
1.55M
企业价值/息税折旧摊销前利润(TTM)
3.03

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

AI 分析 of Organigram Global Inc (OGI)

买入

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

估值指标

Organigram Global Inc(OGI)当前预期市盈率为 15.02,5 年平均预期市盈率为 1.47。

预期市盈率

合理
5 年均值 P/E
1.47
当前P/E
15.02
高估
49.92
低估
-46.97

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-34.26
当前EV/EBITDA
3.03
高估
201.70
低估
-270.23

预期市销率

低估
5 年均值 P/S
1.59
当前P/S
0.30
高估
2.78
低估
0.39

Alphio AI 对 OGI 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%OGI

$1.86

情景价格

基

基准

基准 · 50%OGI

$1.64

情景价格

悲

悲观

悲观 · 25%OGI

$1.37

情景价格

事件时间线

2026-11-03 (ET)

16:30:00

Apple Warns of Margin Drop, Mixed Day for Markets

12:00:00

Apple Warns of Margin Drop, Markets Mixed

09:30:00

Organigram to Acquire Aurora at C$7.80 per Share, Valuing Transaction at Approximately C$561 Million

09:30:00

Organigram to Acquire Aurora Cannabis for C$7.80 per Share

08:30:00

Organigram Holdings Trading Halted, News Pending

资讯

OGI 常见问题 —— 由 Alphio AI 解答

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易